MicroRNAs in liver disease

G Szabo, S Bala - Nature reviews Gastroenterology & hepatology, 2013 - nature.com
Small, noncoding microRNAs (miRNAs) regulate diverse biological functions in the liver and
increasing evidence suggests that they have a role in liver pathology. This Review …

Biomarkers for the diagnosis and post-Kasai portoenterostomy prognosis of biliary atresia: a systematic review and meta-analysis

L He, DKM Ip, G Tam, VCH Lui, PKH Tam… - Scientific reports, 2021 - nature.com
To evaluate the accuracy of biomarkers for the early diagnosis of biliary atresia (BA) and
prognostic stratification after Kasai portoenterostomy (KPE). We conducted a systematic …

Epigenetic regulation of the DLK1-MEG3 microRNA cluster in human type 2 diabetic islets

V Kameswaran, NC Bramswig, LB McKenna, M Penn… - Cell metabolism, 2014 - cell.com
Type 2 diabetes mellitus (T2DM) is a complex disease characterized by the inability of the
insulin-producing β cells in the endocrine pancreas to overcome insulin resistance in …

[PDF][PDF] Epigenetic regulation of connective tissue growth factor by MicroRNA‐214 delivery in exosomes from mouse or human hepatic stellate cells

L Chen, A Charrier, Y Zhou, R Chen, B Yu… - …, 2014 - Wiley Online Library
Connective tissue growth factor (CCN2) drives fibrogenesis in hepatic stellate cells (HSC).
Here we show that CCN2 up‐regulation in fibrotic or steatotic livers, or in culture‐activated …

Large-scale proteomics identifies MMP-7 as a sentinel of epithelial injury and of biliary atresia

C Lertudomphonwanit, R Mourya, L Fei… - Science translational …, 2017 - science.org
Biliary atresia is a progressive infantile cholangiopathy of complex pathogenesis. Although
early diagnosis and surgery are the best predictors of treatment response, current diagnostic …

[PDF][PDF] Biliary atresia in children: update on disease mechanism, therapies, and patient outcomes

S Antala, SA Taylor - Clinics in liver disease, 2022 - Elsevier
Biliary atresia is a rare disease but remains the most common indication for pediatric liver
transplantation as there are no effective medical therapies to slow progression after …

Neonatal cholestasis–differential diagnoses, current diagnostic procedures, and treatment

T Götze, H Blessing, C Grillhösl, P Gerner… - Frontiers in …, 2015 - frontiersin.org
Cholestatic jaundice in early infancy is a complex diagnostic problem. Misdiagnosis of
cholestasis as physiologic jaundice delays the identification of severe liver diseases. In the …

Biliary atresia: pathology, etiology and pathogenesis

M Vij, M Rela - Future science OA, 2020 - Taylor & Francis
Biliary atresia is a progressive fibrosing obstructive cholangiopathy of the intrahepatic and
extrahepatic biliary system, resulting in obstruction of bile flow and neonatal jaundice …

Circulating microRNAs: emerging biomarkers of liver disease

M Arrese, A Eguchi, AE Feldstein - Seminars in liver disease, 2015 - thieme-connect.com
Development of reliable, noninvasive biomarkers that allow for diagnosis, risk stratification,
and monitoring of disease changes over time or in response to specific therapies represents …

Biliary atresia: Clinical advances and perspectives

L Nizery, C Chardot, S Sissaoui, C Capito… - Clinics and research in …, 2016 - Elsevier
Biliary atresia (BA) is a rare and severe inflammatory and obliterative cholangiopathy that
affects both extra-and intrahepatic bile ducts. BA symptoms occur shortly after birth with …